Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...

At AI Dev 26 x SF today, Actian, the data and AI division of HCLSoftware, announced Actian VectorAI DB, a portable vector database purpose-built to power production AI in regulated, disconnected, and ...

Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...

The first vector-delivered gene therapies to receive FDA approval for clinical use were Luxturna,1 Spark Therapeutics’ vision loss cure, and Zolgensma,2 Novartis’ spinal muscular atrophy treatment.

A study on vector database and AI integration identifies unstable indexing, weak cross-modal fusion, and rigid resource ...